Abstract PS3-03-08: Initial results from RECAST DCIS: Multicenter platform trial testing active surveillance and novel endocrine therapy agents for DCIS management
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Institutions: University of Utah, University of California, San Francisco, University of California, Los Angeles, University of Minnesota, Duke University, Main Line Health, Emory University, University of Chicago, Vanderbilt University, Wake Forest University, Englewood Hospital and Medical Center, Quantum Leap Healthcare Collaborative
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7130717131
Cites:
Cited by:
Related to:
